
Pantoseal-IR 40mg/150mg Tablet
Marketer
Organic Laboratories
Salt Composition
Pantoprazole (40mg) + Itopride (150mg)
Overview Pantoseal-IR 40mg/150mg Tablet
Gastro-esophageal reflux disease (GERD) and functional dyspepsia are effectively managed with the 40mg/150mg Pantoseal-IR tablet. This medication alleviates symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Pantoseal-IR should be taken on an empty stomach, following your physician's prescribed dosage and duration. Treatment adherence is crucial; premature cessation may lead to symptom recurrence and disease exacerbation. Comprehensive disclosure of all other medications to your healthcare provider is essential due to potential interactions. Common, generally transient side effects include diarrhea, abdominal pain, headache, flatulence, and hypersalivation. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to potential additive sleepiness. Lifestyle adjustments, such as consuming cool milk and avoiding stimulants like coffee, tea, spicy foods, and chocolate, can enhance treatment outcomes. Pre-treatment disclosure of kidney disease, pregnancy (planned or current), or breastfeeding is vital for your doctor to assess treatment suitability.
Uses of Pantoseal-IR 40mg/150mg Tablet
Stomach acid regurgitation (GERD)
Major Benefits of Pantoseal-IR 40mg/150mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Pantoseal-IR 40mg/150mg tablets on an empty stomach.
Common Side effects of Pantoseal-IR 40mg/150mg Tablet:
- Diarrhea
- Stomach pain
- Headache
- Flatulence
- Dizziness
- Increased saliva production
- Dryness in mouth
How to use Pantoseal-IR 40mg/150mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or dividing it. Consume Pantoseal-IR 40mg/150mg tablets on an empty stomach.
How Pantoseal-IR 40mg/150mg Tablet works:
Pantoseal-IR 40mg/150mg tablets contain pantoprazole, a proton pump inhibitor (PPI), and itopride, a prokinetic agent. Pantoprazole diminishes stomach acid production, alleviating heartburn and acid indigestion. Itopride, by influencing the brain's vomiting center and stimulating upper gastrointestinal motility, facilitates smoother food passage through the digestive system.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Pantoseal-IR 40mg/150mg tablets with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on Pantoseal-IR 40mg/150mg Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Pantoseal-IR 40mg/150mg tablets with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Pantoseal-IR 40mg/150mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Pantoseal-IR 40mg/150mg Tablet use in individuals with renal impairment. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Pantoseal-IR 40mg/150mg tablets in patients with liver disease is likely safe. Existing evidence indicates that dose modification may not be necessary for this patient group. However, physician consultation is recommended.
What if you forget to take Pantoseal-IR 40mg/150mg Tablet :
Should you forget a Pantoseal-IR 40mg/150mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Pantoseal-IR 40mg/150mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
